| Targeted deletion of PD-1 in myeloid cells induces antitumor immunity L Strauss, MAA Mahmoud, JD Weaver, NM Tijaro-Ovalle, A Christofides, ... Science immunology 5 (43), eaay1863, 2020 | 355 | 2020 |
| SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses A Christofides, XL Katopodi, C Cao, D Karagkouni, K Aliazis, ... Nature Immunology 24 (1), 55-68, 2023 | 35 | 2023 |
| Metabolic targets for improvement of allogeneic hematopoietic stem cell transplantation and graft-vs.-host disease NM Tijaro-Ovalle, T Karantanos, HT Wang, VA Boussiotis Frontiers in immunology 10, 436771, 2019 | 21 | 2019 |
| T cell metabolism in cancer immunotherapy HI Aksoylar, NM Tijaro-Ovalle, VA Boussiotis, N Patsoukis Immunometabolism 2 (3), e200020, 2020 | 19 | 2020 |
| Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4+ and CD8+ T effector memory cells and … T Karantanos, HT Kim, NM Tijaro-Ovalle, L Li, C Cutler, JH Antin, K Ballen, ... Clinical Immunology 207, 18-23, 2019 | 12 | 2019 |
| Targeted deletion of PD-1 in myeloid cells induces antitumor immunity. Sci. Immunol. 5, eaay1863 L Strauss, MAA Mahmoud, JD Weaver, NM Tijaro-Ovalle, A Christofides, ... | 10 | 2020 |
| T cell metabolism in cancer immunotherapy. Immunometabolism 2 (3): e200020 HI Aksoylar, NM Tijaro-Ovalle, VA Boussiotis, N Patsoukis | 5 | 2020 |
| Commentary on: combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy A Christofides, NM Tijaro-Ovalle, VA Boussiotis Immunometabolism 3 (2), e210016, 2021 | 3 | 2021 |
| A novel digital educational strategy improves treatment adherence and quality of life in patients with multiple myeloma J Guio, A Melo, MM Saldarriaga, C Fuentes, N Tíjaro-Ovalle, A Borda, ... Journal of Cancer Education 39 (1), 50-57, 2024 | 1 | 2024 |
| Improving Quality of Life and Treatment Adherence in Multiple Myeloma Patients Using Education Strategies Based on Digital and Spaced Learning JFF Guio Oros, ML Romero Prieto, A Borda, G Quintero, C Agudelo Lopez, ... Blood 140 (Supplement 1), 13085-13087, 2022 | 1 | 2022 |
| Pparα ablation suppresses T cell responses and anti-tumor immunity by compromising the antigen-presenting properties of tumor-associated Macrophages A Christofides, C Cao, Q Wang, NM Tijaro-Ovalle, E Konstantinidou, ... Blood 138, 438, 2021 | 1 | 2021 |
| Assessment of a multi-cytokine profile by a novel biochip-based assay allows correlation of cytokine profiles with clinical outcomes in adult recipients of umbilical cord blood … T Karantanos, HT Kim, NM Tijaro-Ovalle, L Li, C Cutler, JH Antin, ... Bone marrow transplantation 55 (9), 1821-1823, 2020 | 1 | 2020 |
| Development of HHV-6-specific immunity after cord blood transplantation in adults depends on reconstitution of thymopoiesis and regeneration of CD4+ T cells NM Tijaro-Ovalle, S Li, Z Defilipp, I Politikos, RM Joyce, P Armand, VT Ho, ... Blood 134, 3275, 2019 | 1 | 2019 |
| SHP-2 and canonical PD-1: SHP-2 axis regulate myeloid cell differentiation, anti-tumor responses and innate immune memory V Boussiotis, A Christofides, XL Katopodi, C Cao, HI Aksoylar, ... | | 2022 |
| Myeloid-Specific SHP-2 Ablation Induces Robust Anti-Tumor Immunity That Is Not Further Enhanced By PD-1 Blockade A Christofides, NM Tijaro-Ovalle, HI Aksoylar, R Pal, AAA Mahmoud, ... Blood 136, 25-26, 2020 | | 2020 |
